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Background: Interleukin-17 (IL-17) is involved in neutrophil recruitment and may contribute to the 
progression from fatty liver to steatohepatitis. Its role in alcoholics and in HCV-infected patients is not 
clear, lower- or higher-than normal values having been reported.
Aim: To study the behavior of IL-17 among alcoholics with or without Hepatitis C virus infection 
(HCV), given the frequent association of both entities and the apparently opposite results reported in 
these two groups of patients.
Results: Among 96 alcoholics, 10 with co-existing HCV infection, 15 non-alcoholic HCV-infected 
patients and 21 controls, IL-17 showed signifi cant differences between patients (median=2.76; IQ=0.85-
5.50) and controls (median=0.50; IQ= 0.30-1.54; Z=3.06, p=0.002). Also, IL-17 was signifi cantly different 
when the sample was classifi ed in 4 groups (alcoholics without HCV infection, alcoholics with HCV 
infection, non-alcoholics, HCV infected patients, and controls (KW= 11.86; p=0.008).
Main fi ndings: By two way variance analysis we disclosed that both hepatitis C (F=7.36; p=0.008) and 
alcohol consumption (F=6.16; p=0.014) exerted signifi cant effects on IL-17, a negative interaction existing 
between both variables (F=4.97; p=0.028). Inverse correlations were observed between left leg fat and 
IL-17 (ρ= -0.28; p= 0.009). Patients with IL-17 over the median showed less trunk fat than those with IL-17 
below the median (Z=2.072; p=0.038), and also less total body fat (Z=1.99; p=0.046). No relations were 
observed between IL-17 and viral load, ethanol consumption or liver function impairment.
Conclusion: Ethanol and HCV infection lead to increased IL-17 levels, similar to what is observed 
when both factors coexist. An inverse relationship exists between body fat and IL-17.
Brief Summary: Interleukin-17 is a cytokine produced by lymphocytes involved in neutrophil 
recruitment that may have a role in the progression from fatty liver to steatohepatitis. Its role in alcoholics 
and in HCV-infected patients is controversial. We here report higher IL-17 levels in alcoholic and HCV-
infected patients. Additionally, we also describe an inverse relationship between IL-17 levels and fat mass 
which supports an inhibitory role of this cytokine on adipogenesis. To our knowledge, no other study has 
analysed the relative and combined effects of HCV and ethanol on IL-17 levels, as we have done in this 
study.
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Background
Interleukin (IL)-17A (IL-17) is the main product of a subset 
of CD4+ T-lymphocytes (T helper (Th)-17 lymphocytes) 
[1], but it can also be secreted by other cells, including -T 
cells, natural killer and natural killer T cells, macrophages, 
Paneth cells and other cell types involved in innate immunity 
[2]. Differentiation of CD4+ cells into Th-17 lymphocytes is 
promoted by several cytokines, such as IL-6, transforming 
growth factor (TGF)-, and IL-21, (in mice) and IL-1, IL-6 and 
IL-23 in humans [3], whereas IL-4 and interferon- (IFNG) 
exert inhibitory effects [4]. Although Th-17 lymphocytes 
regulate the immune response mainly via secretion of IL-
17A and IL-17F, orchestrating the defence especially against 
fungal species [5] and several bacteria, such as Listeria 
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monocytogenes [6], Mycobacterium tuberculosis [7], Klebsiella 
or Staphylococcus aureus [8], they are also involved in the 
pathogenesis of immune-mediated diseases, such as systemic 
lupus erythematosus, among others [9]. 
Interleukin 17 is involved in neutrophil recruitment. 
Receptors for IL-17 are found in all liver cells [10]. In this 
sense, IL-17 activates Kupffer cells, stellate cells, epithelial 
cells and hepatocytes, in which stimulation by IL-17 induces 
the production of acute phase reactants [11] and the expression 
of several cytokines, including IL-8, which is a potent 
chemoattractant for neutrophils. Th-17 lymphocytes infi ltrate 
the liver in alcoholic liver disease, and IL-17 levels are markedly 
increased in plasma in these patients. In liver preparations, 
there is a relationship between the intensity of fi brosis and Th-
17 infi ltration, as shown in a study by Lemmers, et al., [12]. In 
that study, the authors also reported that plasma IL-17 levels 
were increased in alcoholics, but not in patients with hepatitis 
C virus (HCV) - related liver cirrhosis [12]. Controversy exists, 
indeed, regarding the role of IL-17 in HCV-infected patients. 
Some authors report low IL-17 levels among these patients [13], 
but others an opposite result: increased IL-17 in HCV- infected 
patients in association with progression to cirrhosis and with 
viral RNA titer [14]. In a similar sense, it has been postulated 
that Th-17 cells may be also involved in the progression from 
fatty liver to steatohepatitis, at least in non-alcoholic patients 
[15]. 
Therefore, the behaviour of IL-17 in alcoholic or HCV-
infected patients is unclear, and it is not known what happens 
when both factors, HCV infection and alcoholism, co-exist in 
the same patient, a clinically common situation. 
Based on these facts, in this study we aim to analyse the 
behaviour of plasma IL-17 in alcoholic patients with or without 
HCV infection, and non-alcoholic HCV- infected patients, 




We included 111 patients (98 men); 96 of them were 
alcoholics, who drank a median amount of 150 g ethanol per 
day (interquartile range (IQ) =96-212) during 32 years; IQ=21-
40 years. Twenty fi ve patients were affected by chronic HCV 
infection, 15 of them non-drinkers and 10 alcoholics. We 
also included 21 controls (19 men, p=0.54 using the exact 
Fisher´s test when sex was compared in patients and controls). 
Therefore, there were 4 groups: non-HCV infected alcoholics 
(86 patients); HCV-infected alcoholics (10 patients); HCV-
infected non alcoholics (15 patients) and 21 controls. The 
mean age of the patients was 54.14 ± 12.48 years (median=55; 
IQ=47-61 years), while controls had a mean age of 51.86 ± 7.11 
years (median=51; IQ=48-58 years; t=1.18; NS). HCV infection 
was assessed by the presence of anti-HCV antibodies and/or 
HCV RNA measured using reverse transcriptase polymerase 
chain reaction. HCV genotypes included 10 genotype 1a, 4 
genotype 1b, 3 genotype 1, 1 genotype 1a and 1b, 2 genotype 3, 
and 3 genotype 3a. All of these patients were recruited before 
a treatment for virus C hepatitis was administered. Serological 
tests for detection of human immunodefi ciency virus (HIV) 
infection were performed in all patients; those patients with a 
positive test were excluded from this study.
Eighty-nine patients underwent an abdominal ultrasound 
examination. We recorded the presence (38) or not (51) 
of liver steatosis and the presence (38) or not (51) of data 
of liver cirrhosis (heterogeneous liver, portal dilatation, 
splenomegaly). An inverse association was found between the 
presence of steatosis and cirrhosis (2 =6.15; p=0.013).
Nutritional evaluation
Nutritional evaluation was assessed by
1. - Body mass index (BMI) was calculated as weight (in 
kg)/height2 (in m). 
2. - Subjective nutritional evaluation, according to the 
following protocol: the muscle masses of the upper and 
lower limbs and of the temporal muscle were examined , 
defi ning absence of atrophy and two degrees of atrophy 
(moderate or severe), and assigning 0, 1 and 2 points 
to each category, respectively. We also measured fat 
loss by physical examination. We recorded fat loss on 
the cheek and abdomen, Bichat´s fat and subcutaneous 
abdominal fat atrophy, and classifi ed them in a 
similar way, defi ning a score (SNS), based on the sum 
of the assigned points, for which the poorest value 
was 10 and 0 the best one. We further classifi ed our 
patients in well-nourished (Global score= 0-2 points), 
moderately undernourished (3-4 points) and severely 
undernourished (5-10 points), since this classifi cation 
is related to prognosis [16].
3. - Whole body composition by densitometry
After informed consent, patients underwent assessment 
of lean mass and fat mass at different body parts, such as 
arms, legs, trunk, and total body, with a HOLOGIC QDR-2000 
(Waltham, MA, USA). This procedure was performed in 90 
patients.
Cytokines and biochemical parameters
Blood samples were taken at 8.00 a.m. in fasting conditions 
and were immediately frozen at −20°C. Serum IL-17 levels were 
determined by Luminex® Performance Assay (R&D Systems, 
Minneapolis, MN, USA). Sensitivity stated by the manufacturer 
was less than 15 pg/ml, whereas the intra-assay precision was 
6.2%.The detection limit assessed in our laboratory was 0.42 
pg/ml, based on measurement of the intensity of the color of 
the solution contained in the well that includes a monoclonal 
antibody specifi c for human IL-17 and the serum sample to be 
analyzed.
In addition to IL-17 determination, routine laboratory 
evaluation was also performed. Main results of this laboratory 
evaluation are shown in Table 1.
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Statistics
The Kolmogorov-Smirnov test was used to test for normal 
distribution, a condition not fulfi lled by most of the variables. 
Therefore, non-parametric tests, such as Mann-Whitney´s U 
test and Kruskall-Wallis were used to analyse differences of 
these parameters between groups. Student´s t test, variance 
analysis and Pearson´s correlation analysis were used with the 
few variables with a normal distribution, whereas Spearman´s 
rho (instead of Pearson´s correlation) was utilised in the case 
of non-parametric variables. Non parametric variables are 
given as median and interquartile range, whereas parametric 
variables are shown as means ± standard deviations. 
In order to assess whether alcohol or HCV infection exerted 
an independent effect on IL-17 levels, and whether or not there 
was an interaction between both parameters, we used a two-
way variance analysis. These analysis were performed with the 
SPSS program (Chicago, Ill., USA).
The study protocol was approved by the local ethical 
committee of our Hospital (2014-11) and conforms to the 
ethical guidelines of the 1975 Declaration of Helsinki.
Results
IL-17 showed highly signifi cant differences between 
patients (median= 2.76; IQ=0.85-5.50 pg/ml) and controls 
(median=0.50; IQ= 0.30-1.54 pg/ml; Z=3.06, p=0.002). Also, IL-
17 was signifi cantly different when the sample was classifi ed 
in 4 groups (alcoholics without HCV infection, alcoholics with 
HCV infection, non-alcoholics, HCV infected patients, and 
controls (KW= 11.86; p=0.008, Table 1, Figure 1). By two way 
variance analysis we disclosed that both hepatitis C (F=7.36; 
p=0.008) and alcohol consumption (F=6.16; p=0.014) exerted 
signifi cant effects on IL-17, an interaction existing between 
both variables (F=4.97; p=0.028). Similar results were observed 
when only men were included (KW=10.44, p=0.015 when IL-17 
was compared among the 4 groups; signifi cant effects of both 
HCV infection (F=6.51; p=0.012 and ethanol (F=5.14; p=0.025; 
and signifi cant interaction (F=4.21; p=0.043) between ethanol 
and HCV infection). There were no differences among men 
(median=2.98; IQ=1.20-5.50 pg/ml) and women (median=2.50; 
IQ=0.17-5 pg/ml; Z=0.96; non-signifi cant (NS)), and IL-17 
values were not associated with age (=-0.07; NS). When only 
women were subjected to statistical analysis, no differences 
were observed among the 4 groups, and we failed to fi nd 
any signifi cant effects of HCV and/or ethanol on IL-17 levels 
(probably because the short number of women included).
Ethanol consumption and liver function
No association was observed between IL-17 and the 
amount of ethanol consumed (=0.06), the duration of the 
drinking habit (=0.011) or the levels of GGT (=0.02) and 
MCV values (=0.04), either by Spearman´s correlation or by 
Mann Whitney´s U test comparing patients with IL-17 over the 
median or below the median. 
Among patients with HCV infection the negative correlation 
between IL-17 and viral load (23 patients) was not statistically 
signifi cant (=-0.32; p=0.14), and there were no differences 
in viral load when patients with IL-17 over the median were 
compared with those with IL-17 values below the median 
(Z=1.13; NS).
We also failed to fi nd any association between IL-17 
and prothrombin activity (=-0.04), serum albumin (=-
Table 1: Some data of the individuals included in the study. Data are given either as means ± standard deviations or medians (interquartile ranges).
HCV- alcoholics (n=86; 80 men) HCV + alcoholics (n=10; 9 men) HCV+ , non-alcoholics (n=15; 9 men) Controls (n=21; 19 men)
Serum IL-17 (pg/ml) 2.5 (0.81-5) 2.68 (2-5.88) 4.2 (1.1-7.30) 0.5 (0.3-1.55)
Age 57.08 ± 11.54 49.40 ± 13.66 41.87 ± 9.50 51.86 ± 7.10
ASAT (U/L) 47.5 (22-94.25) 90.5 (42-189) 42 (32-65) Normal 7-40
ALAT (U/L) 29.5 (19-56.25) 75 (46.5-104.75) 47 (36-68) Normal 7-40
GGT (U/L) 186 (51-361) 198.5 (78.75-388.5) 56 (24-106) Normal 7-40
Alkaline phosphatase (U/L)  84 (58-120) 106.5 (82.5-165) 78 (58-87) Normal= 40-129
Prothrombin (%)  79.85 (58.30-99.0) 100 (60.5-100) 100 (100-100) Normal 80-100
Serum albumin (g/dL)  3.60 ± 0.72 3.61 ± 0.78  4.47 ± 0.32 Normal 3.8-4.5
Serum bilirubin (mg/dL)  1 (1-2.85) 1.1 (0.68-1.75)  0.6(0.4-0.7) Normal <1.4
Total neutrophils (per mm3)  4170 (3075-6298) 4138 (2993-5982) 3519 (2917-5324) Normal=1700-7000
Total lymphocytes (per mm3) 1165 (828-1423) 1662 (923-2217) 2217 (1819-2992) Normal=1000-4800
Mean corpuscular volumen (fl )  101.30 ± 9.03 99.29 ± 5.59 90.7v1 ± 2.68 Normal= 80-100
Daily ethanol (g) 150 (100-225) 110 (80-200)  ---------------- --------------
Years of addiction  32 ± 14 33 ± 19  ------------- --------------
Body mass index 25.72 (23.85-28.54) 23.02 (21.19-28.01) 22.86 (21.0-24.31) 25 (23-28)
Viral load (Log) ------------------ 5.13 ± 2.31  6.28 ± 0.64 ----------------
Total fat mass (g) 19638 (14393-29368) 18509 (10172-22545) 18804 (9572- 24857) ---------------
Trunk fat mass (g) 11577 (9069-18100) 10734 (5539-13693) 9380 (4937-13480) ---------------
Total lean mass (g)  48125 (45087-53911) 43594 (35133- 45838) 22877 (18543-42030) ---------------
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0.02) or bilirubin (=0.02), or the presence of ascites (24 
cases; median=3.48; IQ=1.43-5.95 vs 2.50; IQ=0.5-4.83 pg/
ml; Z=1.25; NS) or encephalopathy (14 cases; median=4; 
IQ=1.98-9.24 vs 2.5; IQ=0.81-4.83 pg/ml; Z=1.39; NS). There 
were also no differences in IL-17 between patients with liver 
steatosis (median=3.5; IQ=1.4-6.5 pg/ml) and those without 
liver steatosis (median=2.63; IQ=0.5-5.33 pg/ml; Z=1.11; NS), 
or among patients with ultrasonographic features of liver 
cirrhosis (median=2.76; IQ=0.81-5.65 pg/ml)or without these 
features (median=2.27; IQ=0.85-4.83 pg/ml; Z=0.4; NS).
We also failed to fi nd any signifi cant relationship between 
IL-17 and the variables mentioned before when only men were 
considered. 
Relationships with lean and fat mass 
Fifty patients had normal nutritional status according to 
subjective nutritional score, 30 were moderately undernourished 
and 27, severely undernourished. No relationship existed 
between IL-17 levels and subjective nutritional evaluation 
(KW=0.06; NS). Also, no relationship was observed between 
IL-17 and BMI (=0.09; NS).
No associations were observed with body lean mass. 
In general, inverse correlations were observed with fat 
distribution, but these correlations were statistically signifi cant 
only between left leg fat and IL-17 (= -0.28; p= 0.009). 
Patients with IL-17 over the median showed less trunk fat than 
those with IL-17 below the median (Z=2.072; p=0.038), and 
also less total body fat (Z=1.99; p=0.046; Figures 2a,b). These 
differences were also observed when only men were analysed 
(Z=2.14, p=0.032 for total fat, and Z=2.16, p=0.031 for trunk 
fat). 
Discussion
In this study we have shown that both alcoholism and 
HCV infection lead to increased IL-17 levels, but when both 
conditions coexist, the degree of increase is less remarkable. 
As mentioned previously, Lemmers, et al., reported for the 
fi rst time high IL-17 levels among alcoholics, accompanied by 
an increase in peripheral Il-17 producing mononuclear cells 
(PBMC), and by infi ltration of the liver by IL-17 secreting 
cells. Liver infi ltration by IL-17 secreting cells correlated with 
liver function impairment assessed by MELD score, but a 
paradoxical inverse correlation was observed between plasma 
levels of IL-17 and liver function impairment [12]. In the same 
study the authors also failed to fi nd any differences in IL-
17 values between patients with HCV infection and controls. 
On the contrary other authors have found higher plasma IL-
17 values among patients with HCV infection. In this sense, 
our data for controls and HCV patients are similar to those 
reported by Hammad, et al., (1.2 ± 0.4 pg/mL for controls and 
6.42 ± 1.7 pg/mL for non-complicated HCV-infected patients) 
[14]. In Hammad´s study the development of liver cirrhosis 
or hepatocellular carcinoma led to an enormous rise in IL-17 
levels. Other researchers have found that IL-17 plays a key role 
in the progression of HCV infection, and also a marked decrease 
in the proportion of IL-17 producing peripheral PBMC after 
Figure 1: IL-17 among the four groups of individuals included in the study (Controls, 
pure alcoholics, pure HCV-infected patients and alcoholic + HCV infection).
Figure 2a: Differences in total fat comparing patients with serum IL-17 values over 
the median or below the median.
Figure 2b: Differences in trunk fat comparing patients with serum IL-17values over 
the median or below the median.
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interferon therapy [17]. Reda, et al., have found signifi cantly 
increased IL-17 values in HCV-infected patients that were 
signifi cantly related to liver function impairment [18]. Other 
authors report normal values in HCV-infected patients 
compared with controls (8.35 ± 3.42 pg/ml vs 13.15 ± 6.80 pg/
ml, p = 0.088 in El Bassuoni study), [19] and Sousa, et al., also 
reported even lower IL-17 levels in HCV-infected patients than 
in controls, in the range of those reported in our study [13]. 
Hao, et al., also failed to fi nd differences between controls 
and 114 HCV –infected patients [20]. Therefore, a great deal 
of controversy exists regarding the role of Th17 cells in HCV 
infection. A prevailing hypothesis states that IL-17 would 
increase in these patients as a compensatory mechanism, 
rather than as a mechanism directly involved in liver damage 
[13]. To our knowledge no other study has analysed the relative 
and combined effects of HCV and ethanol on IL-17 levels, as 
we have done in this study. Although we did fi nd that HCV 
infection was accompanied by an increase in IL-17 levels, no 
association was found with viral load, in accordance with other 
authors [13,20]. Similarly, although IL-17 was also increased 
in alcoholics, we also failed to fi nd any association with daily 
ethanol intake or duration of alcoholism. Moreover, differences 
between the group of patients in whom alcoholism and HCV 
infection coexisted and pure alcoholics and non-alcoholic 
HCV infected patients were small, probably lacking clinical 
relevance. 
The role of IL-17 in liver disease is still controversial 
[21]. Most studies have been performed among patients with 
nonalcoholic fatty liver disease (NAFLD). This entity nowadays 
constitutes the most common form of liver injury [22]. Both 
in alcoholic and non-alcoholic patients, fatty liver can be 
considered as a multifactorial process, in which an initial 
feature, biochemically characterized by an increased deposition 
of triglycerides within the hepatocyte triggers a cascade of 
events ultimately leading to increased infl ammation, liver 
fi brosis, cirrhosis, and hepatocellular carcinoma [23]. 
The obesity pandemic is strongly related to the 
increasing prevalence of fatty liver [22]. Adipose tissue is 
an active endocrine organ, able to secrete proinfl ammatory 
cytokines, among other adipokines. Interleukin-6, produced 
by adipocytes, is a key inducer of the transformation of 
T-helper naive cells into Th-17, IL-17 secreting cells [24]. 
This fact probably contributes to the increased expression 
of IL-17 observed in obese individuals, [25] and it has been 
postulated that the neutrophils´chemoattractant properties of 
IL-17 may play a role in the progression of liver steatosis to 
steatohepatitis [26,27]. Indeed, several authors have reported 
increased plasma IL-17 levels in obese patients [28], but there 
are exceptions to this fi nding. Zapata- Guerrero, et al., studied 
morbidly obese women and found lower IL-17 levels than in 
controls [29]. Jung, et al., in 2016 also report lower levels of IL-
17 in overweight adolescents than in lean controls [30]. These 
authors also report lower IL-17 levels in mice in whom obesity 
was induced by a high fat diet consumption than in controls. 
These last results are in accordance with what we observed in 
this study: there was an inverse relationship between total fat 
and trunk fat, assessed by whole body densitometry, and IL-17 
levels. Moreover, there are data that support an inhibitory role 
of IL-17 on adipogenesis [31]. 
Therefore we conclude that IL-17 is increased in alcoholic 
patients and HCV –infected patients, and also when both 
factors coincide in the same patient. However, this increase is 
not related to ethanol consumption, viral load, or liver function 
impairment, but, inversely, with total body fat and trunk fat, 
a result in accordance with some observations that support an 
inhibitory role of IL-17 on adipogenesis.
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